Table 5.
Prevalence of obesity-related comorbidities according to weight status categories in 2020.
| Underweight n = 3154 | Normal weight n = 24,244 | Overweight n = 4911 | Obesity n = 4528 | P | |
|---|---|---|---|---|---|
| Type 2 DM/ IGT | 23 (0.7%) | 261 (1.1%) | 70 (1.4%) | 75 (1.7%) | <0.001 |
| OSA | 17 (0.5%) | 176 (0.7%) | 40 (0.8%) | 80 (1.8%) | <0.001 |
| PTC | 1 (<0.001%) | 22 (0.1%) | 7 (0.1%) | 23 (0.5%) | <0.001 |
| Hypertension | 11 (0.3%) | 85 (0.4%) | 40 (0.8%) | 58 (1.3%) | <0.001 |
| Dyslipidemia | 33 (1.0%) | 309 (1.3%) | 89 (1.8%) | 118 (2.6%) | <0.001 |
| NAFLD | 4 (0.1%) | 27 (0.1%) | 37 (0.8%) | 121 (2.7%) | <0.001 |
Data are presented as number (percent). P values represent Pearson’s chi-square tests.
DM diabetes mellitus, IGT impaired glucose tolerance, OSA obstructive sleep apnea, PTC pseudotumor cerebri, NAFLD non-alcoholic fatty liver disease.